Overview
- 81 inspections across 72 sites are on record.
- 375 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-05.
At a glance
Inspections
81
Sites
72
Observations
375
Career since
Jul 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Endo USA, Inc. | 5 Jun 2026 | Human Drugs | On file |
| PPL Healthcare LLC | 8 May 2026 | Human Drugs | View 483 → |
| Granules Pharmaceuticals Inc. | 3 Apr 2026 | Human Drugs | View 483 → |
| Aphena Pharma Solutions - Maryland, LLC | 20 Feb 2026 | Human Drugs | View 483 → |
| Veranova LP | 23 Jan 2026 | Human Drugs | On file |
Sites inspected
Endo USA, Inc.Horsham, United States1 insp.
PPL Healthcare LLCSellersville, United States1 insp.
Granules Pharmaceuticals Inc.Chantilly, United States1 insp.
Aphena Pharma Solutions - Maryland, LLCEaston, United States1 insp.
Veranova LPWest Deptford, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Kenneth H Williams6 shared
Craig D Zagata6 shared
Kara J Wright4 shared
Daniel J Min4 shared
Christina K Theodorou4 shared
Daniel T Lee3 shared
Lisa Shin3 shared
Freddy Ortiz Colon3 shared
Matthew R Noonan3 shared
Ofuje D Daniyan2 shared
Full investigator report
Get the verbatim findings behind David A Oluwo's 375 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site